AED: antiepileptic drug, VPA: Valproate, LEV: Levetiracetam, CBZ: Carbamazepine, TPM: Topiramate
Table 2. Main Outcomes Difference between baseline and follow-up
Control group Control group Control group Intervention group Intervention group Intervention group
Outcome Baseline (n=40) Follow-up (n=35) P-value Baseline (n=41) Follow-up (n=36) P-value
Efficacy n (%) 11 (27.5%) 17 (48.6%) <0.05* 13 (31.7%) 23 (63.9%) <0.001**
Safety Mean (SD) 21.42 (12.16) 23.73 (13.24) <0.001** 21.08 (10.59) 18.91 (9.44) <0.001**
Adherence§ Mean (SD) 6.05 (1.26) 5.85 (1.43) >0.05 6.04 (1.09) 7.61 (0.9) <0.001**
Satisfaction Mean (SD) 2.2 (2.76) 2.66 (2.68) <0.05* 0.76 (1.4) 12.58 (1.4) <0.0001**
QoL Mean (SD) 70.88 (20.7) 64.63 (21.58) <0.05* 70.75 (14.5) 75.09 (14.87) <0.001**
Difference between groups at follow-up Difference between groups at follow-up Difference between groups at follow-up Difference between groups at follow-up Difference between groups at follow-up Difference between groups at follow-up Difference between groups at follow-up
Outcome Control group Control group Control group Intervention group Intervention group P-value
Efficacy 17 (48.6%) 17 (48.6%) 17 (48.6%) 23 (63.9%) 23 (63.9%) >0.05
Safety 23.73 (13.24) 23.73 (13.24) 23.73 (13.24) 18.91 (9.44) 18.91 (9.44) >0.05
Adherence§ 5.85 (1.43) 5.85 (1.43) 5.85 (1.43) 7.61 (0.9) 7.61 (0.9) <0.0001**
satisfaction 2.66 (2.68) 2.66 (2.68) 2.66 (2.68) 12.58 (1.4) 12.58 (1.4) <0.0001**
QoL 64.63 (21.58) 64.63 (21.58) 64.63 (21.58) 75.09 (14.87) 75.09 (14.87) <0.05*